Vaccines

Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You

  • by

Scientists and lawmakers agree that over-the-counter covid tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel. This story also ran on Fortune. It can be republished for free. But even as entrepreneurs race their… Read More »Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You

In California, Blue Shield’s Vaccination Takeover Fixes What Wasn’t Broken

  • by

In California’s Mendocino County, public health officials and community clinics say they have hit their vaccination stride. This story also ran on The Mendocino Beacon. It can be republished for free. Despite the county’s remoteness and its largely rural population spread among wooded mountains, rugged… Read More »In California, Blue Shield’s Vaccination Takeover Fixes What Wasn’t Broken

Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink

  • by

Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to… Read More »Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink

AstraZeneca updates Covid-19 vaccine data, now showing 76% efficacy

  • by

AstraZeneca’s latest efficacy data for its Covid-19 vaccine are down slightly from the 79% it previously reported. The most recent data will form the basis of an application for emergency use authorization, which the company still expects to file with the FDA in coming weeks.

Stop Blaming Tuskegee, Critics Say. It’s Not an ‘Excuse’ for Current Medical Racism.

  • by

For months, journalists, politicians and health officials — including New York Gov. Andrew Cuomo and Dr. Anthony Fauci — have invoked the infamous Tuskegee syphilis study to explain why Black Americans are more hesitant than white Americans to get the coronavirus vaccine. This story is… Read More »Stop Blaming Tuskegee, Critics Say. It’s Not an ‘Excuse’ for Current Medical Racism.

AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions

  • by

Federal health authorities say safety observers are concerned AstraZeneca did not release complete information about the efficacy of its Covid-18 vaccine. The company responded by saying its data were from a pre-specified analysis and it will provide the most up to date efficacy data within… Read More »AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions

ViewPoints Interview: SiO2’s Lawrence Ganti Shares Insight on the Efforts to Scale Up the Manufacturing of Vials for COVID-19 Vaccines

  • by

In an interview with PharmaShots, Lawrence Ganti, President & Chief Business Officer at SiO2 Materials Science shared his views on the efforts to scale up the manufacturing of vials to combat COVID-19. Additionally, he also shared the benefits of using SiO2’s smart vials and shed… Read More »ViewPoints Interview: SiO2’s Lawrence Ganti Shares Insight on the Efforts to Scale Up the Manufacturing of Vials for COVID-19 Vaccines

‘Press 1 for English’: Vaccination Sign-Ups Prove Daunting for Speakers of Other Languages

  • by

In late February, a week after Virginia launched a centralized website and call center for covid-19 vaccine preregistration, Zowee Aquino alerted the state to a glitch that could prove fatal for non-English speakers trying to secure a shot. This story also ran on U.S. News… Read More »‘Press 1 for English’: Vaccination Sign-Ups Prove Daunting for Speakers of Other Languages

Landmark Covid Relief Law Pumps More Than $100 Billion Into Public Health

  • by

Acknowledging that chronic underfunding of public health contributed significantly to the nation’s fragmented response to the coronavirus pandemic, Democrats included more than $100 billion in the recently enacted relief package to address urgent needs and enhance future efforts. Use Our Content It can be republished… Read More »Landmark Covid Relief Law Pumps More Than $100 Billion Into Public Health

A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out

  • by

As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of… Read More »A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out

Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations?

  • by

This analysis examines the extent to which early vaccination efforts through community health centers are reaching people of color using data from the federal government’s weekly Health Center COVID-19 Survey. Additionally, this analysis may shed light on the Biden administration’s recent partnership with health centers… Read More »Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations?

How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?

  • by

This brief reviews information available through state websites and publicly available vaccine distribution plans to provide greater insight into how states are addressing equity through vaccine allocation and distribution strategies, outreach and communications efforts, and data collection and reporting. It provides a snapshot and examples… Read More »How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?

KFF COVID-19 Vaccine Monitor Probes Americans’ Experiences Trying to Sign Up for a Vaccine and to Find Relevant Information

  • by

Many Relied on Another Person’s Help to Try to Get a Vaccine Appointment As many states and local authorities ramp up their COVID-19 vaccination efforts, the latest KFF COVID-19 Vaccine Monitor report provides the first in-depth look at Americans’ experiences trying to gather relevant information… Read More »KFF COVID-19 Vaccine Monitor Probes Americans’ Experiences Trying to Sign Up for a Vaccine and to Find Relevant Information

ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines

  • by

Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have made unprecedented progress in advancing treatments and vaccines to help fight COVID-19. At this time, three vaccines and several treatments have… Read More »ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines

Kaiser Permanente, Big Player in California Vaccine Effort, Has Had Trouble Vaccinating Own Members

  • by

USE OUR CONTENT It can be republished for free. As managed-care giant Kaiser Permanente assumes a prominent role in California’s new covid-19 vaccination strategy, it is drawing mixed reviews from members across the country for the way it has run its own vaccine program over… Read More »Kaiser Permanente, Big Player in California Vaccine Effort, Has Had Trouble Vaccinating Own Members

How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

  • by

Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other supplies and increasing manufacturing capacity to get COVID-19 vaccine shots in as many arms as possible. Even… Read More »How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

THE CONVERSATION: Between Us, About Us, A New Campaign By Black Health Care Workers for Black People about the COVID-19 Vaccines

  • by

March 4, 2021 – THE CONVERSATION: Between Us, About Us. is a new campaign to provide Black communities with credible information about the COVID-19 vaccines co-developed by KFF (Kaiser Family Foundation) and the Black Coalition Against COVID. Black doctors, nurses and researchers dispel misinformation and… Read More »THE CONVERSATION: Between Us, About Us, A New Campaign By Black Health Care Workers for Black People about the COVID-19 Vaccines

In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites

  • by

This story is part of a partnership that includes KPCC, NPR and KHN. It can be republished for free. In California, confusion and botched communication has caused some eligible parents and family caregivers of people with disabilities to be turned away at covid vaccination sites.… Read More »In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites

Many Nonelderly People With Disabilities Face COVID-19 Risks Similar to Those of the Elderly in Nursing Homes, But Do Not Have Equal Footing When it Comes to Vaccine Priority

  • by

While the toll of COVID-19 on nursing home residents has been well documented, less noticed has been the experience of nonelderly people with disabilities who rely on long-term care services and supports outside of nursing homes. In many ways the two groups face similar health… Read More »Many Nonelderly People With Disabilities Face COVID-19 Risks Similar to Those of the Elderly in Nursing Homes, But Do Not Have Equal Footing When it Comes to Vaccine Priority

Connecticut Is Doling Out Vaccines Based Strictly on Age. It’s Simpler, but Is it Fair?

  • by

With covid vaccines expected to remain scarce into early spring, Connecticut has scrapped its complicated plans to prioritize immunizations for people under 65 with certain chronic conditions and front-line workers. Instead, the state will primarily base eligibility on age. Gov. Ned Lamont pointed to statistics… Read More »Connecticut Is Doling Out Vaccines Based Strictly on Age. It’s Simpler, but Is it Fair?

Most Americans Now Say They’ve Gotten At Least One Dose of a COVID-19 Vaccine or Want to Get Vaccinated As Soon As Possible, with Enthusiasm Rising Across Racial, Ethnic and Partisan Groups

  • by

While Enthusiasm Rises, a Persistent Minority Say They Definitely Will Not Get Vaccinated; Republicans, Rural Residents, and Essential Workers Outside Health Care Are Most Reluctant Groups More than half of Americans (55%) now say they want to get vaccinated as soon as possible (37%) or… Read More »Most Americans Now Say They’ve Gotten At Least One Dose of a COVID-19 Vaccine or Want to Get Vaccinated As Soon As Possible, with Enthusiasm Rising Across Racial, Ethnic and Partisan Groups

States Have Made Progress in Vaccinating Older Adults Against COVID-19 in Recent Weeks, But No State Has Vaccinated At Least Half of its Older Population

  • by

Twenty-two states and the District of Columbia have vaccinated at least one-third of their residents who are 65 and older against COVID-19, an updated KFF analysis finds, but no state has crossed the threshold of vaccinating 50 percent or more of its older population. The share… Read More »States Have Made Progress in Vaccinating Older Adults Against COVID-19 in Recent Weeks, But No State Has Vaccinated At Least Half of its Older Population

Why AstraZeneca and J&J’s Vaccines, In Use the World Over, Are Still on Hold in America

  • by

This story also ran on Fortune. It can be republished for free. The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting it… Read More »Why AstraZeneca and J&J’s Vaccines, In Use the World Over, Are Still on Hold in America

COVID-19 Cases and Deaths Among Nursing Home Residents Have Declined Markedly Following the Introduction of Vaccines

  • by

The number of residents contracting and dying of COVID-19 in nursing homes has declined markedly following the introduction of vaccination efforts in long-term care facilities, a KFF analysis finds. Resident deaths from COVID-19 in nursing homes have decreased by two-thirds (66%) since vaccination efforts began… Read More »COVID-19 Cases and Deaths Among Nursing Home Residents Have Declined Markedly Following the Introduction of Vaccines

Is the End of the Long-Term Care Crisis Within Sight? New COVID-19 Cases and Deaths in Long-Term Care Facilities Are Dropping

  • by

This analysis compares trends in new COVID-19 cases and deaths among nursing facility residents with trends in all other new COVID-19 cases and deaths excluding nursing facility residents through February 7, 2021. This analysis shows a marked divergence in new cases and deaths per week… Read More »Is the End of the Long-Term Care Crisis Within Sight? New COVID-19 Cases and Deaths in Long-Term Care Facilities Are Dropping

Fighting variants of COVID-19

  • by

As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. To date, two vaccines have been granted Emergency Use Authorization (EUA) in the United States by the U.S. Food… Read More »Fighting variants of COVID-19

Countless Homebound Patients Still Wait for Covid Vaccine Despite Seniors’ Priority

  • by

This story also ran on CNN. It can be republished for free. Opening another front in the nation’s response to the pandemic, medical centers and other health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound seniors. Boston… Read More »Countless Homebound Patients Still Wait for Covid Vaccine Despite Seniors’ Priority

New Analysis: Updated State Data Continues To Show Wide Disparities in COVID-19 Vaccination Rates by Race/Ethnicity

  • by

KFF has an updated analysis of state-reported data as of February 16, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity. New to the analysis are comparisons of vaccination rates in each racial/ethnic group based on state-reported data of total people who have received at… Read More »New Analysis: Updated State Data Continues To Show Wide Disparities in COVID-19 Vaccination Rates by Race/Ethnicity

Family Caregivers, Routinely Left Off Vaccine Lists, Worry What Would Happen ‘If I Get Sick’

  • by

Robin Davidson entered the lobby of Houston Methodist Hospital, where her 89-year-old father, Joe, was being treated for a flare-up of congestive heart failure. This story also ran on CNN. It can be republished for free. Before her stretched a line of people waiting to… Read More »Family Caregivers, Routinely Left Off Vaccine Lists, Worry What Would Happen ‘If I Get Sick’

Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple

  • by

“Pfizer and Moderna could share their design with dozens of other pharma companies who stand ready to produce their vaccines and end the pandemic.” — Feb. 3 in a Facebook post This story was produced in partnership with PolitiFact. It can be republished for free. Vaccine… Read More »Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple

This Week in Coronavirus: February 5 to February 11

  • by

During the 55th week since the first coronavirus case appeared in the United States, the world is at nearly 108 million COVID-19 cases. The U.S. approached 27.4 million cases and a total of 475,400 deaths.

In Search of the Shot

  • by

Too little covid vaccine and too great a demand: That’s what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system. Public health officials say the… Read More »In Search of the Shot

Scalise’s Claim That Unauthorized Immigrants Are Getting Priority for Vaccination Misses the Point

  • by

“Now he [Biden] is saying that people who came here illegally can jump ahead of other Americans who have been waiting to get the vaccine.” Rep. Steve Scalise (R-La.) During a Feb. 2 interview on Fox News, Rep. Steve Scalise (R-La.) claimed President Joe Biden… Read More »Scalise’s Claim That Unauthorized Immigrants Are Getting Priority for Vaccination Misses the Point

KFF COVID-19 Vaccine Monitor: In Their Own Words

  • by

This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,

CureVac Collaborate with UK Government to Develop Vaccines Against SARS-CoV-2 variants

  • by

Shots: The collaboration combines expertise, resources and technology from both parties to develop and manufacture variant vaccines against SARS-CoV-2 variants. CureVac is expected to supply 50M doses of variant vaccines to the UK, following the regulatory approval The VTF and the CureVac will deploy mRNA… Read More »CureVac Collaborate with UK Government to Develop Vaccines Against SARS-CoV-2 variants

With Demand Far Exceeding Supply, It Matters That People Are Jumping the Vaccine Line

  • by

This story also ran on The New York Times. It can be republished for free. The Biden administration’s much-needed national strategy to end the covid-19 pandemic includes plans to remedy the chaotic vaccination effort with “more people, more places, more supply.” The Federal Emergency Management… Read More »With Demand Far Exceeding Supply, It Matters That People Are Jumping the Vaccine Line

KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies

  • by

Can’t see the audio player? Click here to listen on SoundCloud. Thursday was “health day” in President Joe Biden’s sprint to launch his presidency, and he signed two executive orders addressing health coverage and women’s reproductive rights. The orders will reopen enrollment under the Affordable Care… Read More »KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

  • by

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir. That was surprising because the antiviral drug, owned by… Read More »Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December

  • by

Most Convincing Messages to Promote Vaccination Highlight Effectiveness at Preventing Illness and a Return to Normal Life; Hearing about Rare Allergic Reactions and Side Effects May Discourage Some New KFF Dashboard Features Key Data and Insights from the Vaccine Monitor With millions of Americans getting… Read More »Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December

Por qué ni siquiera la presión presidencial podría acelerar las vacunas contra covid

  • by

Miles de estadounidenses están muriendo a causa de covid-19, pero los esfuerzos para aumentar la producción de vacunas que potencialmente salvan vidas están en un callejón sin salida. Moderna y Pfizer-BioNTech, los fabricantes de las dos vacunas disponibles hasta el momento, están operando al máximo,… Read More »Por qué ni siquiera la presión presidencial podría acelerar las vacunas contra covid

‘We’re Not Controlling It in Our Schools’: Covid Safety Lapses Abound Across US

  • by

Computer science teacher Suzy Lebo saw covid-19 dangers frequently in her Indiana high school: classes with about 30 students sitting less than 18 inches apart. Students crowding teachers in hallways. Students and staff members taking off their masks around others. “I’m concerned,” said Lebo, who… Read More »‘We’re Not Controlling It in Our Schools’: Covid Safety Lapses Abound Across US

Anti-Vaccine Activists Peddle Theories That Covid Shots Are Deadly, Undermining Vaccination

  • by

Anti-vaccine groups are exploiting the suffering and death of people who happen to fall ill after receiving a covid shot, threatening to undermine the largest vaccination campaign in U.S. history. In some cases, anti-vaccine activists are fabricating stories of deaths that never occurred. “This is… Read More »Anti-Vaccine Activists Peddle Theories That Covid Shots Are Deadly, Undermining Vaccination

This Week in Coronavirus: January 15 to January 21

  • by

During the 52nd week since the first coronavirus case appeared in the United States, the U.S. surpassed 24.6 million total cases and 410,100 deaths due to the pandemic. Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism.

New Resources Track State Vaccinations by Race/Ethnicity and Examine Demographics of Health Workers

  • by

A new Policy Watch, Early State Vaccination Data Raise Warning Flags for Racial Equity, explores the latest state-reported data on vaccination by race/ethnicity available on KFF’s COVID-19 state data and policy tracker. As of January 19, 2021, 17 states were reporting some vaccination data by… Read More »New Resources Track State Vaccinations by Race/Ethnicity and Examine Demographics of Health Workers

Nearly 6 in 10 Older Americans Don’t Know When or Where They Can Get a COVID-19 Vaccine; Black and Hispanic Adults among the Groups Least Likely to Have Enough Information

  • by

Despite Optimism about COVID-19 Vaccines in the Future, Half Say They are Frustrated with the Current Situation and Nearly a Quarter are Angry While older Americans are a high-priority group for getting a COVID-19 vaccine, the latest KFF COVID-19 Vaccine Monitor report finds that, among those who… Read More »Nearly 6 in 10 Older Americans Don’t Know When or Where They Can Get a COVID-19 Vaccine; Black and Hispanic Adults among the Groups Least Likely to Have Enough Information

KFF COVID-19 Vaccine Monitor: January 2021

  • by

This KFF COVID-19 Vaccine Monitor report finds many people, including older adults and essential workers, do not have enough information about where and when to receive a vaccine. It also looks at views of vaccine distribution and the federal and state efforts.

This Week in Coronavirus: January 8 to January 14

  • by

During the 51st week since the first coronavirus case appeared in the United States, the U.S. surpassed 23.3 million total cases and 388,700 deaths due to the pandemic. Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism.

Vaccine Hesitancy Among Hispanic Adults

  • by

Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among Hispanic Americans toward the coronavirus and a generational gap in willingness to get a potential vaccine.

California Counties ‘Flying the Plane as We Build It’ in a Plodding Vaccine Rollout

  • by

USE OUR CONTENT It can be republished for free. In these first lumbering weeks of the largest vaccination campaign in U.S. history, Dr. Julie Vaishampayan has had a battlefront view of a daunting logistical operation. Vaishampayan is the health officer in Stanislaus County, an almond-growing… Read More »California Counties ‘Flying the Plane as We Build It’ in a Plodding Vaccine Rollout

Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted

  • by

For Heather Suri, a registered nurse in Virginia, the race to vaccinate Americans against covid has thrown up some unprecedented obstacles. The vaccines themselves are delicate and require a fair bit of focus over time. Consider Moderna’s instructions for preparing its doses: Select the number… Read More »Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted

New Analysis Takes In-Depth Look at How States are Prioritizing Who Gets a COVID-19 Vaccine

  • by

A new KFF analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. Based on… Read More »New Analysis Takes In-Depth Look at How States are Prioritizing Who Gets a COVID-19 Vaccine